Mc. Raymond et al., STUDIES ON THE STRUCTURE-ACTIVITY OF MOTILIN IN-VIVO - EFFECT OF MOTILIN SYNTHETIC ANALOGS IN CONSCIOUS DOG, Regulatory peptides, 50(2), 1994, pp. 121-126
Synthetic analogues of motilin were tested for their capacity to stimu
late the intestinal motor activity of the conscious dog. Physiological
doses (75 pmol/kg) of motilin 1-22 and of motilin fragments 1-21, 1-2
0 and 1-19 induced premature periods of phase III activity in all test
ed animals. Motilin fragments 1-15, 1-12, 1-11 and 1-10 failed to infl
uence the intestinal myoelectrical activity even when given at doses 1
0-times superior (750 pmol/kg). Motilin-like-immunoreactivity was meas
ured in plasma during the analogues infusion. During the infusion of t
he bioactive analogues (1-22, 1-21, 1-20, 1-19), plasma motilin increa
sed by 174 +/- 25 fmol/ml while a small rise (22 +/- 7.6 fmol) was not
ed with the inactive fragments (P < 0.001). Our data are in agreement
with the in vitro findings that the N-terminal portion of the motilin
molecule is responsable for its biological activity and suggests that
the middle portion of the molecule is important to prevent degradation
and maintain biological activity in vivo.